Derma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/26/2026

1. INTC
2. DECK
3. AMD
4. META
5. INFY
6. RNG
7. TMUS
8. SPY
9. UNP
10. GOOGL

Go back to Derma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal

Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products

July 28, 2016 7:30 AM EDT

Immediately accretive transaction will bring four proprietary high-margin product families and revenue of $22 million for the trailing 12 months ended June 30, 2016 Will add 235 independent sales representatives and seven direct sales representatives with no call-point or customer overlap BioD shareholders to make concurrent $2 million equity investment

Conference call to be held today at 9:00 a.m. Eastern time

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue... More

Derma Sciences to Sell First Aid Products Division for Approximately $12.2 Million

July 27, 2016 7:30 AM EDT

Company also realized $7.6 million of proceeds from the sale of Comvita Limited common stock during the second quarter

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to sell its First Aid Division (FAD) to Dukal Corporation for approximately $12.2 million, including inventory. Dukal is a privately-held supplier of a broad range of best-in-class disposable medical products and patient-care items for all medical markets, with headquarters in... More